Climb Bio, Inc. Reports Results for Quarter Ended June 30, 2026

What Happened

• Climb Bio, Inc. announced its financial results for the quarter ended June 30, 2026 in a press release issued August 6, 2026. The company filed a Form 8-K (Item 2.02) to report its results and attached the press release as Exhibit 99.1. The filing was signed by Aoife Brennan, M.B., Ch.B., President and Chief Executive Officer.

Key Details

• Filing date: August 6, 2026 (Form 8-K).
• Reporting item: Item 2.02 — Results of Operations and Financial Condition.
• Period covered: Quarter ended June 30, 2026.
• Exhibit: 99.1 — press release announcing the quarter’s results (also referenced under Item 9.01).

Why It Matters

• The 8-K signals Climb Bio has publicly released its latest quarterly financial and operational information; investors should review the attached press release for details on earnings, revenue, cash position, guidance, or program updates that could affect the company’s valuation.
• Because the 8-K itself only attaches the press release, retail investors should read Exhibit 99.1 for the specific figures and management commentary and monitor subsequent filings or investor calls for any additional context.